SCHLAP1 is a longnoncoding RNA that is prognostic for progression to metastatic prostate cancer and promotes an invasive phenotype. SCHLAP1 is reported to function by depleting the core SWI/SNF subunit, SMARCB1, from the genome. SWI/SNF is a large, multisubunit, chromatin remodeling complex that can be combinatorially assembled to yield hundreds to thousands of distinct complexes.
Main
The long non coding RNA (lncRNA) Second Chromosome Locus Associated with Prostate cancer 1 ( SCHLAP1 ) is prognostic for metastatic disease and is a promising biomarker in prostate cancer 1, 2 .
SCHLAP1 is proposed to function by antagonizing the SWI/SNF complex through direct interaction leading to complete disruption of SWI/SNF genomic occupancy 1 . Evidence for this mechanism comes from the reported loss of SMARCB1 occupancy measured by ChIPseq 1 . SWI/SNF is a large multisubunit chromatin remodeling complex that can be combinatorially assembled to yield hundreds to thousands of biochemically distinct complexes, each of which may have unique functions [3] [4] [5] [6] . We investigated the alternate hypothesis that distinct forms of SWI/SNF are affected in disparate ways through SCHLAP1 expression. However, a variety of biochemical and genomics assays we demonstrate that SWI/SNF occupancy is unaffected by SCHLAP1 expression, in contrast to previously reported results. SCHLAP1 expression induces changes to chromatin state measured by ATACseq, but does not lead to changes in histone modification states. Using RNA immunoprecipitation we show that SWI/SNF binds both coding and noncoding RNA, raising the possibility that the reported SCHLAP1 SWI/SNF interaction is due a broad interaction between RNA and SWI/SNF and that SCHLAP1 may function through another mechanism.
We hypothesized that SCHLAP1 expression affected the composition and occupancy of SWI/SNF complexes in prostate cancer. We first validated the reported interaction between SMARCB1 and SCHLAP1 using 22Rv1 and LNCaP prostate cancer cells. Consistent with the previous report we observed an interaction between SMARCB1 and SCHLAP1 ( Fig. 1A) . We next wished to study SWI/SNF dynamics in a controlled model system. To do this we generated SCHLAP1 overexpressing benign prostate epithelial cells (RWPE1; SCHLAP1 ) or control cells (RWPE1; LACZ ) 1 ( SCHLAP1 construct gift of A. Chinnayian). This model is the same one used to originally suggest global depletion of SMARCB1 by SCHLAP1 1 . Similar to the results of Prensner et. al., we saw strong induction of SCHLAP1 in these cells upon overexpression, and we did not observe any changes in SWI/SNF subunit expression at the protein level ( Fig 1B, Supp. Fig. 1A ) . Expression of SCHLAP1 did not induce changes to proliferation in twodimensional culture, and did not affect the ability of RWPE1 cells to grow from low cell numbers in lowadherent plates (Supp. Fig. 1B, C) , consistent with the previous reports.
Finally, we assessed the functional change demonstrated previously by performing invasion assays on RWPE1; LACZ and RWPE1; SCHLAP1 . This confirmed an increase in invasion by cells expressing SCHLAP1 ( Fig 1C) .
Together these results show our model faithfully recapitulates the previous functional aspects of SCHLAP1 overexpression in RWPE1 cells and we validated the physical interaction between SCHLAP1 and SMARCB1 1 .
To investigate which SWI/SNF subunits were depleted from chromatin upon SCHLAP1 expression, we fractionated the RWPE1; LACZ and RWPE1; SCHLAP1 cells into cytosolic, soluble nuclear, and insoluble chromatin enriched fractions 7 . Surprisingly, all SWI/SNF subunits assayed remained strongly enriched in the chromatin fraction and we observed no gross differences between RWPE1; LACZ and RWPE1; SCHLAP1 (Fig. 1D) . We tested the association with chromatin using an orthologous biochemical method by using varying concentrations of salt to extract chromatin associated proteins 8 .
Consistent with our fractionation experiments, SWI/SNF subunits in both cell lines were extracted from nuclei under higher salt conditions in fractions containing histone H3 in both RWPE1; Lacz and RWPE1; SCHLAP1 cells. SWI/SNF localized to distinct salt fractions compared to the nonchromatin associated protein βtubulin and the arginine methyltransferase CARM1 (Fig. 1E ). Consistent with these biochemical experiments, we found that SMARCA4 and SMARCB1 localization was not affected in RWPE1; SCHLAP1 cells by immunofluorescence ( Fig. 1F ). Next, we performed coimmunoprecipitation for SMARCA4 and SMARCB1 and found that several SWI/SNF complex members could be immunoprecipitated together (Supp. Fig 1D) . This demonstrates that the SWI/SNF complex remains intact in the presence of SCHLAP1 . Finally, we used a malignant rhabdoid tumor cell line where SMARCB1 can be induced by culturing cells with doxycycline (Kind gift of B. Weissman).
The expression of SMARCB1 in these cells causes growth arrest 9 . We reasoned that if SCHLAP1 disrupted SMARCB1 chromatin occupancy, overexpression of SCHLAP1 should allow G401 to continue growing following induction of SMARCB1. However, SMARCB1 induction led to growth arrest in a dose dependent manner in both cell lines (Supp. Fig. 2AC ) . Together these results demonstrate that SCHLAP1 does not induce changes to SWI/SNF composition or association with chromatin.
To validate these biochemical results we performed ChIPseq for three SWI/SNF subunits in RWPE1; SCHLAP1 cells. We used the core subunit SMARCB1, which was previously assayed by Prensner et al., as well as both ATPase subunits, SMARCA2 and SMARCA4 . In contrast to the previous report, we identify robust binding for all three subunits in RWPE1 cells expressing SCHLAP1 ( Fig. 2A) . In RWPE1; SCHLAP1 cells we identified 6490, 22185, and 51505 peaks for SMARCB1, SMARCA2, and SMARCA4 respectively (Supplemental Table 1 ). This large number of peaks is in contrast to the original report which identified ~6500 SMARCB1 peaks in RWPE1; LACZ cells and nearly zero peaks in the SCHLAP1 expressing cells. The numbers of peaks are consistent with previous work from our lab showing 30,00045,000 SMARCA4 peaks 10 . Additionally we and others have reported a large number of SWI/SNF peaks for a variety of subunits 3, [10] [11] [12] . The vast majority of SMARCA2 peaks overlapped a SMARCA4 peak, consistent with our previous results 10 (Fig. 2B ). The differences in numbers of peaks between subunits is likely due to differences in antibody efficiency, or subunits that are less accessible to DNA and cross linking relative to the rest of the complex. SWI/SNF peaks were predominantly located at promoters (45%75% Fig. 2C ) , with SMARCA4 having the most nonpromoter peaks (~55% nonpromoter). We monitored signal across all annotated transcription start sites in GENCODE and identified concordant strong signal across approximately 25% of TSS. SWI/SNF binding was most prominent at highly expressed genes with little to no occupancy at nonexpressed genes ( Fig. 2D , GSE98898 for expression data) 13 . Table 2 ) . The sites that opened were more likely to be located distally or in introns of genes ( Figure 3A, B) . Sites that open upon SCHLAP1 expression were enriched for distinct motifs from those that close (Supp. Fig 3A, Supplemental Table 3 , 4) . Open sites were enriched in motifs for TEAD and AP1 transcription factors. AP1 and TEAD motifs were closely spaced consistent with a potential role in oncogenic enhancers [15] [16] [17] . To test if these sites became activated enhancers, we performed ChIPseq for H3K4me1, H3K4me3, and H3K27ac in RWPE1; LACZ and RWPE1; SCHLAP1 cells ( Fig. 3C ). No major differences were identified when comparing ChIPseq signaling between RWPE1; LACZ and RWPE1; SCHLAP1 cells. We looked at whether SWI/SNF subunits were localized to the dynamic ATAC sites. SMARCA2, SMARCA4, and SMARCB1 were more highly enriched in RWPE1; SCHLAP1 on sites that lose chromatin accessibility suggesting that SWI/SNF remains occupied at these sites in the presence of SCHLAP1 . GO analysis of the genes associated with open sites revealed pathways involved in responses to NFKB signaling, epithelial to mesenchymal transitions, and nucleotide metabolism (Supp. Fig 3B) . Genes associated with closed sites were enriched for pathways involved in cell adhesion and signal transduction via RAS, MAPK, and WNT (Supp. Fig 3B) . As SCHLAP1 did not exert broad effects on SWI/SNF occupancy, we next investigated whether SWI/SNF interacts with other lncRNA. Numerous reports suggest a role for lncRNASWI/SNF interactions [18] [19] [20] [21] [22] [23] . We performed crosslinked RIPseq for SMARCA4 and a general splicing factor that would not be expected to have a similar interactions as a chromatin remodeler ( Splicing Factor Proline And Glutamine Rich SFPQ ) in 22Rv1 cells in LNCaP cells (Fig. 4A ) 24 . Consistent with previous observations of chromatin regulators, we saw widespread enrichment of SMARCA4 on most expressed transcripts relative to an IgG control (Supplemental Table 5 , 6) 24 . The pattern of SWI/SNF enrichment appeared relatively uniform throughout the transcript, including introns, suggesting SMARCA4
associates frequently with primary transcripts ( Fig 4CF) . In contrast, SFPQ had more restricted binding patterns, with most enrichment on exons and high levels of enrichment at the 3' UTR of many transcripts. We observed SMARCA4 and SFPQ signal at SCHLAP1 , although the level of enrichment was not strong or markedly different between the proteins. Among the enriched transcripts was NEAT1 , which is a known interacting partner of both SWI/SNF 19 and SFPQ 25, 26 . SFPQ is believed to play a role in alternate isoform usage of NEAT1 through regulating 3' end processing, and its binding pattern at SFPQ reflects a role on both the short and long isoforms ( Fig. 4A , short arrow) 27 . Additionally, we identified high levels of SMARCA4 associated with MALAT1, while SFPQ was lower at this gene ( Fig   4A,B) . A recent report showed a functional interaction between SMARCA4, HDAC9, and MALAT1, further supporting the specificity of our result 23 . The broad pattern of enrichment suggests SWI/SNF may have a frequent interaction with RNA that might not be sequence specific.
Together these results demonstrate that the interaction between SWI/SNF and SCHLAP1 does not lead to a global depletion of SWI/SNF from the genome as previously reported 1 . However, we confirm that SCHLAP1 induces RWPE1 cells to become more invasive, and our results suggest that this phenotype may be driven by a SWI/SNF independent mechanism. As SCHLAP1 has shown prognostic value for identifying metastatic prostate cancer, it is important to identify the mechanism by which it promotes invasion 2 . SCHLAP1 expression induces moderate changes to chromatin but appear insufficient to drive changes to histone modifications ( Fig. 3 ). Our RNA immunoprecipitation results suggest that SWI/SNF interactions with RNA may be widespread, as reported for other chromatin regulators 24 . In vitro, RNA is capable of inhibiting chromatin remodeling activity and this may provide a mechanism of regulating chromatin remodeling activity via locusspecific broad SWI/SNFRNA interactions 22 . Future studies are needed to improve our understanding of how widespread interactions between chromatin remodelers and RNA affect chromatin and transcription.
Methods
Cell Culture RWPE1 cells were purchased from ATCC ( CRL11609, Lot 61840713 ) and grown in Keratinocyte Serum Free Medium (Life Technologies ) supplemented with penicillin and streptomycin. Cells were STR profiled by ATCC before purchase, and all experiments were performed on low passage cells (< 10 passages). Lenti6 SCHLAP1 was a kind gift of A. Chinnayian 1 . Lenti6Lacz was generated by removing SCHLAP1 from the above plasmid and cloning LACZ from pLentipuroLACZ into pLenti6 from which SChLAP1 was removed by EcoRIBamHI digest. Lentiviral particles were produced using psPAX2 and pMD2.G to package plasmids in 293T cells. RWPE1; Lacz and RWPE1; SCHLAP1 cells were then generated by transduction with lentivirus and selecting with 2.5ug/mL blasticidin for 1 week.
22RV1 and LNCaP Cells were purchased from ATCC (CRL2505, Lot 60437301; CRL1740, Lot 62129998) and grown in RPMI 1640 with 10% Fetal Bovine Serum supplemented with penicillin and streptomycin. Cells were STR profiled by ATCC prior to purchase and were used at early passages ( < 10 passages). All cells were tested and free of mycoplasma contamination. Background fluorescence of the membranes was obtained from a negative control.
Antibodies

RNA Immunoprecipitation
RIP experiments were performed using a modified version of a protocol from Hendrickson et al.. 24 Fixation 22Rv1 and LNCaP cells were fixed in 0.3% methanol free formaldehyde for 30 minutes at 4 . Formaldehyde was quenched with 125mM glycine for 5 minutes at room temperature. Plates were washed 3 times in room temperature PBS and cells were scraped in 1mM PMSF in PBS. Cells were snap frozen in liquid nitrogen and stored at 80 . RNAseq libraries were prepared by using equal volumes of IPs and included 1uL of 1:250uL dilution of ERCC spikein mix 1 (Life Technologies). Input libraries were prepared from the same amount of RNA as the IP with the most RNA, and spikeins were added as above. Libraries were then prepared using the Kapa Ribozero kit per manufacturers instructions, pooled, and sequenced on using singleend 75bp reads on a Nextseq 500.
Fragmentation and IP
RIPseq Analysis
Reads were aligned using STAR to hg38 with gencode v27 annotations that included ERCC spikeins and using quantMode GeneCounts. In parallel an alignmentfree quantitation method (Salmon version 0.8) was used to quantitate against gencode v27 containing ERCC spike ins and an extra transcript for each gene that contained the whole genomic DNA locus to represent an unspliced transcript. Browser tracks were generated by converting BAM files to bigWig files using Deeptools (v 2.5.2) and scaling tracks according to the 75% percentile of the ERCCspike ins. Enrichment relative to IgG was calculated using DESeq2 with sizeFactors generated from only the ERCC spikein data. For visualization relative to Input in Figure 4C ,D,E normalized count values were used and log2 (RIP/Input) was calculated for each gene. RIPseq data are available under GEO accession GSE114393
Chromatin Fractionation
Chromatin fractionation was performed as previously described 7 Growth Assays 2D growth assays were performed by plating 1000 cells/well in 96 well plate and were assayed at 1, 3, and 5 days post plating by Cell Titer Glo (Promega). 3D Growth assays were performed by plating 10 or 100 cells per well in 96well plates and counting cell growth by Cell Titer Glo 3D (Promega) at 4 days following plating.
Immunoprecipitation
Nuclear lysates and coimmunoprecipitation were performed as previously described 10 
ChIPseq
ChIP experiments were performed as previously described 10 . Cells were fixed for 30 min at 4 C in 0.3% methanolfree formaldehyde, quenched for 5 min with 125 mM glycine, washed three times and snapfrozen in liquid nitrogen and stored at -80 C. Frozen pellets were thawed for 30 min on ice, RNaseA for 30 min at 37 C and then proteinase K for 1 h at 56 C and purified with Zymo Clean and Concentrator ChIP Kit and quantified using qubit before library preparation (Kapa Hyperprep).
ChIPseq Analysis
Reads were aligned to hg38 using bowtie2 28 using the sensitive parameters, and duplicates were removed using SAMtools 29 . For visualization, bigwig tracks were generated using DeepTools 30 (version 2.5.2), bamCoverage tool with a binsize of 30 bp and extending fragments to the approximate nucleosome size of 150 bp. Tracks can be visualized using IGV 31 , and bigwig files are available in GEO Accession number GSE114392.
Peak calling
Peaks were called using Macs2 (version 2.1.0 32 ) using the narrowpeak mode using the following parameters. Qval = 0.05 -keepdupall fixbimodal -nomodel -extsize 150. Additionally, we filtered the peaks against the ENCODE blacklist regions. Peaks were then annotated for the nearest transcription start site using ChIPPeakAnno 33 relative to GENCODE v26.
ATACseq
ATACseq was performed as previously described 14 with modifications. Briefly, 50,000 cells were harvested and lysed in a buffer containing 0.05% Ipegal CA630 before transposition with a Nextera library prep kit containing TN5 transposomes. Libraries were amplified using 68 PCR cycles to enrich for TN5 products and add indexes and sequenced as pairedend 50bp libraries on a Hiseq 2500.
ATACseq data are available under GEO Accession number GSE114391.
ATACseq analysis
Nextera adapter sequences were trimmed using trim_galore and reads were aligned to hg38 using bowtie2 with the X 2000 setting 28 . We removed any reads mapping to the mitochondrial genome and filtered any reads with a mapping quality less than 20 using SAMtools 29 . Peaks were called using Macs2 (version 2.1.0 32 ) using the narrowpeak mode using default settings and keepdupall.
Differential openness was identified use csaw 34 with window size 150 and background window size 5000 and an adjusted FDR of 0.05 for the combined windows. Motif analysis was performed using HOMER and comparing the open or closed ATAC sites to the background set of static sites 35 .
Data Availability
All data are available from GEO under accession number GSE114394. 
